PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron

Detalles Bibliográficos
Autores principales: Acharya, Arpan, Pathania, Anup S., Pandey, Kabita, Thurman, Michellie, Vann, Kendra R., Kutateladze, Tatiana G., Challagundala, Kishore B., Durden, Donald L., Byrareddy, Siddappa N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989379/
https://www.ncbi.nlm.nih.gov/pubmed/35390226
http://dx.doi.org/10.1002/ctm2.806
Descripción
Sumario:

Ejemplares similares